BioNexus Gene Lab Corp Common Stock Shares Outstanding

• BioNexus Gene Lab Corp showed an increase of +1.7% in Common Stock Shares Outstanding from 2023 to 2024.
• This data is from BioNexus Gene Lab Corp's annual report (Form 10-K), filed with the SEC on April 15, 2025.
• XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2018 to 2024), BioNexus Gene Lab Corp's Common Stock Shares Outstanding has declined by 75.9%.
• Historical annual values: Fiscal year 2024: 17.97 million shares | Fiscal year 2023: 17.67 million shares | Fiscal year 2022: 14.48 million shares | Fiscal year 2021: 171.22 million shares | Fiscal year 2020: 171.22 million shares | Fiscal year 2019: 102.73 million shares | Fiscal year 2018: 74.63 million shares.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026